Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,595.00
Bid: 2,580.00
Ask: 2,585.00
Change: -15.00 (-0.57%)
Spread: 5.00 (0.194%)
Open: 2,615.00
High: 2,615.00
Low: 2,585.00
Prev. Close: 2,610.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

2 Mar 2020 16:08

RNS Number : 7438E
Morgan Sindall Group PLC
02 March 2020
 

Morgan Sindall Group plc (the "Company")

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

The following notification is intended to satisfy the Company's obligations under Article 19.3 of EU Regulation No 596/2014 (the Market Abuse Regulation).

 

1.

Details of Restricted Person/person closely associated with them ("PCA")

a)

Name

John Morgan (Chief Executive)

Steve Crummett (Finance Director)

2.

Reason for the notification  

a)

Position/status

Members of the Board of directors

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

a)

Name

Morgan Sindall Group plc

b)

LEI

2138008339ULDGZRB345

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 5 pence each

 

ISIN: GB0008085614 

b)

Nature of the transaction

Grant of nil cost share options on 2 March 2020, under the Company's Deferred Bonus Plan, adopted by the Company on 28 November 2017 ("DPB"). The nil cost options granted are equivalent to 30% of the annual bonus earned for the year ended 31 December 2019. Each nil cost option will mature and become exercisable from 2 March 2023. The share price used to determine the number of nil cost options is £18.57. Each nil cost option carries a right to receive, on maturity, an amount linked to dividends paid on the Ordinary Shares subject to the conditional award. The dividend equivalent can be settled in cash or Ordinary shares of the Company.

c)

Price(s) and volume(s)

Name

Price(s)

Volume(s)

John Morgan

N/A

9,758

Steve Crummett

N/A

7,781

d)

Aggregated information

- Aggregated volume

- Price

As above

 

e)

Date of the transaction

2 March 2020

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFLFIRVRIFIII
Date   Source Headline
7th Nov 20137:00 amRNSInterim Management Statement
31st Oct 20132:18 pmRNSTotal Voting Rights
9th Oct 20134:41 pmRNSHolding(s) in Company
30th Sep 20134:48 pmRNSTotal Voting Rights
27th Sep 20131:22 pmRNSDirector/PDMR Shareholding
25th Sep 20135:01 pmRNSHolding(s) in Company
17th Sep 201310:06 amRNSHolding(s) in Company
30th Aug 20133:51 pmRNSTotal Voting Rights
13th Aug 20134:41 pmRNSHolding(s) in Company
13th Aug 201312:04 pmRNS£100m South Shields Regeneration Project
12th Aug 201311:47 amRNSNotifications of Major Interests in Shares
9th Aug 20131:11 pmRNSDirector/PDMR Shareholding
9th Aug 201312:00 pmRNSHolding(s) in Company
5th Aug 20137:00 amRNSHalf Yearly Report
31st Jul 20133:08 pmRNSTotal Voting Rights
11th Jul 20137:00 amRNS£269m Woolwich Redevelopment Programme Award
2nd Jul 20139:23 amRNSDirector Declaration
28th Jun 20132:45 pmRNSTotal Voting Rights
28th Jun 20137:19 amRNSDisposal of PFI interest
26th Jun 20134:17 pmRNSHolding(s) in Company
11th Jun 201310:30 amRNSHolding(s) in Company
31st May 201311:45 amRNSTotal Voting Rights
30th May 20138:11 amRNSBlocklisting Interim Review
24th May 20139:30 amRNSHolding(s) in Company
9th May 20131:53 pmRNSResult of AGM
9th May 20137:00 amRNSAGM and Q1 Interim Management Statement
7th May 20139:00 amRNSMuse Developments appointed preferred bidder
30th Apr 20131:53 pmRNSTotal Voting Rights
16th Apr 20137:00 amRNSLovell signs £63.3m Dagenham homes scheme
8th Apr 201310:12 amRNSHolding(s) in Company
2nd Apr 20139:45 amRNSHolding(s) in Company
28th Mar 20135:22 pmRNSHolding(s) in Company
28th Mar 20133:04 pmRNSTotal Voting Rights
26th Mar 20133:36 pmRNSAnnual Financial Report
20th Mar 20135:36 pmRNSDirector/PDMR Shareholding
15th Mar 20133:39 pmRNSHolding(s) in Company
13th Mar 20135:18 pmRNSHolding(s) in Company
1st Mar 201311:17 amRNSHolding(s) in Company
28th Feb 20133:59 pmRNSTotal Voting Rights
27th Feb 20135:21 pmRNSDirector/PDMR Shareholding
27th Feb 20132:56 pmRNSDirector/PDMR Shareholding
25th Feb 20137:00 amRNSBoard Changes
19th Feb 20137:00 amRNSPreliminary Results
8th Feb 201312:54 pmRNSHolding(s) in Company
8th Feb 201312:52 pmRNSHolding(s) in Company
31st Jan 20135:01 pmRNSTotal Voting Rights
10th Jan 20137:00 amRNSAppointment of Steve Crummett as Finance Director
31st Dec 20128:00 amRNSTotal Voting Rights
18th Dec 20127:00 amRNSPre-Close Statement
11th Dec 20124:43 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.